Details of the Drug Reposition

General Information of This Drug (ID: DMNX3US)

Drug Name
GS-9820   DMNX3US
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Lymphoma DISN6V4S 2A80-2A86 Phase 1 [1]
Chronic lymphocytic leukaemia DISEXWC3 2A82.0 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of Gilead.